ArticleHeliyon2023

Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus.

Nancy E Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.